Debbie Rigby rounds up the latest in research news Treatment options for glucocorticoid-induced osteoporosis Glucocorticoid-induced osteoporosis is the most common form of secondary osteoporosis. It develops in a dose and time dependent manner, due to a rapid and transient increase in bone resorption, followed by the inhibition of bone formation. While oral bisphosphonates remain the
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.